As hemin is a potent BACH1 inhibitor, we then tested whether pharmacologic inhibition of BACH1 using hemin could elicit tumor suppression in vivo similar to shBACH1 when co-treated with an MCT1 inhibitor. The gene discussed is SLC16A1; the disease is neoplasm.